ijms-logo

Journal Browser

Journal Browser

Adipokines in Health and Diseases 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".

Deadline for manuscript submissions: closed (30 May 2022) | Viewed by 15317

Special Issue Editor


E-Mail Website
Guest Editor
Dipartimento di Scienze e Tecnologie Ambientali, Biologiche, Farmaceutiche, Università della Campania “Luigi Vanvitelli”, 81100 Caserta, Italy
Interests: adiponectin; nutrition; health and disease; physical activity; sport; metabolic diseases; immune disorders
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Adipose tissue is not a passive reservoir for energy storage; indeed, it produces several adipocytokines that act on different tissues and organs.

Adipocytokines have attracted increased attention when multiple and pleiotropic effects, in proliferative, inflammatory, and immune responses, show up. The involvement of adipocytokines in the abovementioned processes represents the starting point and the rationale for analyzing the involvement of adipose tissue in health conditions (e.g., different lifestyles, aging) and several diseases (e.g., metabolic diseases, malignancies, immune disorders).

For this 2nd Special Issue, we invite you to contribute with either an original research article or a comprehensive review focusing on the role of adipose tissue or adipokines in the regulation of health and disease or deepening our understanding of the molecular aspects that link this depot of tissues with other organs.

Prof. Dr. Aurora Daniele
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adiponectin
  • adipose tissue
  • adipokines
  • nutrition
  • molecular pathways
  • biomarkers
  • health
  • disease

Related Special Issue

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 1203 KiB  
Article
Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation
by Mark-Alexander Schwarzbich, Hao Dai, Lambros Kordelas, Dietrich W. Beelen, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger and Thomas Luft
Int. J. Mol. Sci. 2022, 23(4), 2337; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23042337 - 20 Feb 2022
Cited by 2 | Viewed by 2025
Abstract
Weight loss and metabolic activity influence outcome after allogeneic stem cell transplantation (alloSCT). This study evaluates pre-conditioning Leptin, a peptide hormone involved in metabolism and immune homeostasis, as a prognostic factor for survival, relapse and non-relapse mortality (NRM) following alloSCT. Leptin serum levels [...] Read more.
Weight loss and metabolic activity influence outcome after allogeneic stem cell transplantation (alloSCT). This study evaluates pre-conditioning Leptin, a peptide hormone involved in metabolism and immune homeostasis, as a prognostic factor for survival, relapse and non-relapse mortality (NRM) following alloSCT. Leptin serum levels prior to conditioning were determined in a cohort of patients transplanted for various hematologic malignancies (n = 524) and correlated retrospectively with clinical outcome. Findings related to patients with acute leukemia (AL) from this sample were validated in an independent cohort. Low pre-conditioning serum Leptin was an independent prognostic marker for increased risk of relapse (but not of NRM and overall mortality) following alloSCT for AL of intermediate and advanced stage (beyond first complete remission). Multivariate analysis revealed a hazard ratio (HR) for relapse of 0.75 per log2 increase (0.59–0.96, p = 0.020). This effect was similar in an independent validation cohort. Pre-conditioning serum Leptin was validated as a prognostic marker for early relapse by fitting the multivariate Cox model to the validation data. Pre-conditioning serum Leptin levels may serve as an independent prognostic marker for relapse following alloSCT in intermediate and advanced stage AL patients. Prospective studies are required to prove whether serum Leptin could be used for guiding nutritional intervention in patients with AL undergoing alloSCT. Full article
(This article belongs to the Special Issue Adipokines in Health and Diseases 2.0)
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 953 KiB  
Review
Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
by Gabriela Barros, Pablo Duran, Ivana Vera and Valmore Bermúdez
Int. J. Mol. Sci. 2022, 23(14), 7499; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23147499 - 06 Jul 2022
Cited by 28 | Viewed by 5080
Abstract
Obesity is a major public health issue worldwide since it is associated with the development of chronic comorbidities such as type 2 diabetes, dyslipidemias, atherosclerosis, some cancer forms and skin diseases, including psoriasis. Scientific evidence has indicated that the possible link between obesity [...] Read more.
Obesity is a major public health issue worldwide since it is associated with the development of chronic comorbidities such as type 2 diabetes, dyslipidemias, atherosclerosis, some cancer forms and skin diseases, including psoriasis. Scientific evidence has indicated that the possible link between obesity and psoriasis may be multifactorial, highlighting dietary habits, lifestyle, certain genetic factors and the microbiome as leading factors in the progress of both pathologies because they are associated with a chronic pro-inflammatory state. Thus, inflammation management in obesity is a plausible target for psoriasis, not only because of the sick adipose tissue secretome profile but also due to the relationship of obesity with the rest of the immune derangements associated with psoriasis initiation and maintenance. Hence, this review will provide a general and molecular overview of the relationship between both pathologies and present recent therapeutic advances in treating this problem. Full article
(This article belongs to the Special Issue Adipokines in Health and Diseases 2.0)
Show Figures

Figure 1

17 pages, 945 KiB  
Review
Multiple Leptin Signalling Pathways in the Control of Metabolism and Fertility: A Means to Different Ends?
by Maggie C. Evans, Rebecca A. Lord and Greg M. Anderson
Int. J. Mol. Sci. 2021, 22(17), 9210; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22179210 - 26 Aug 2021
Cited by 21 | Viewed by 7418
Abstract
The adipocyte-derived ‘satiety promoting’ hormone, leptin, has been identified as a key central regulator of body weight and fertility, such that its absence leads to obesity and infertility. Plasma leptin levels reflect body adiposity, and therefore act as an ‘adipostat’, whereby low leptin [...] Read more.
The adipocyte-derived ‘satiety promoting’ hormone, leptin, has been identified as a key central regulator of body weight and fertility, such that its absence leads to obesity and infertility. Plasma leptin levels reflect body adiposity, and therefore act as an ‘adipostat’, whereby low leptin levels reflect a state of low body adiposity (under-nutrition/starvation) and elevated leptin levels reflect a state of high body adiposity (over-nutrition/obesity). While genetic leptin deficiency is rare, obesity-related leptin resistance is becoming increasingly common. In the absence of adequate leptin sensitivity, leptin is unable to exert its ‘anti-obesity’ effects, thereby exacerbating obesity. Furthermore, extreme leptin resistance and consequent low or absent leptin signalling resembles a state of starvation and can thus lead to infertility. However, leptin resistance occurs on a spectrum, and it is possible to be resistant to leptin’s metabolic effects while retaining leptin’s permissive effects on fertility. This may be because leptin exerts its modulatory effects on energy homeostasis and reproductive function through discrete intracellular signalling pathways, and these pathways are differentially affected by the molecules that promote leptin resistance. This review discusses the potential mechanisms that enable leptin to exert differential control over metabolic and reproductive function in the contexts of healthy leptin signalling and of diet-induced leptin resistance. Full article
(This article belongs to the Special Issue Adipokines in Health and Diseases 2.0)
Show Figures

Figure 1

Back to TopTop